Works matching IS 2160763X AND DT 2018 AND VI 7 AND IP 6
Results: 12
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Mirogabalin When Coadministered With Lorazepam, Zolpidem, Tramadol, or Ethanol: Results From Drug‐Drug Interaction Studies in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 6, p. 597, doi. 10.1002/cpdd.582
- By:
- Publication type:
- Article
Pharmacokinetics of Perampanel in Healthy Korean, White, and Japanese Adult Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 6, p. 613, doi. 10.1002/cpdd.581
- By:
- Publication type:
- Article
Pharmacokinetic Characteristics of Tofacitinib in Adult Patients With Moderate to Severe Chronic Plaque Psoriasis.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 6, p. 587, doi. 10.1002/cpdd.471
- By:
- Publication type:
- Article
Formulation and In Vitro, In Vivo Correlation Between Two Candesartan Cilexetil Tablets.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 6, p. 621, doi. 10.1002/cpdd.460
- By:
- Publication type:
- Article
Pharmacokinetic Interaction Between Fingolimod and Carbamazepine in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 6, p. 575, doi. 10.1002/cpdd.459
- By:
- Publication type:
- Article
Pharmacokinetics, Safety, and Tolerability of Lamotrigine Chewable/Dispersible Tablet Following Repeat‐Dose Administration in Healthy Chinese Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 6, p. 627, doi. 10.1002/cpdd.449
- By:
- Publication type:
- Article
A Randomized, Placebo‐Controlled, Double‐Blind Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Repeated Doses of Mirogabalin in Healthy Asian Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 6, p. 661, doi. 10.1002/cpdd.448
- By:
- Publication type:
- Article
Safety, Pharmacokinetics, and Immunogenicity of Obiltoxaximab After Intramuscular Administration to Healthy Humans.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 6, p. 652, doi. 10.1002/cpdd.410
- By:
- Publication type:
- Article
Effects of High‐ and Low‐Fat Meals on the Pharmacokinetics of Ozanimod, a Novel Sphingosine‐1‐Phosphate Receptor Modulator.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 6, p. 634, doi. 10.1002/cpdd.409
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 6, p. 565, doi. 10.1002/cpdd.403
- Publication type:
- Article
Categorization of Abuse Potential–Related Adverse Events.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 6, p. 569, doi. 10.1002/cpdd.394
- By:
- Publication type:
- Article
A Thorough QT Study to Evaluate the Effects of Supratherapeutic Doses of Ledipasvir on the QTc Interval in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 6, p. 641, doi. 10.1002/cpdd.390
- By:
- Publication type:
- Article